Assessing recurrence risk with ctDNA-based MRD detection in NSCLC patients

In operable non-small cell lung cancer (NSCLC), molecular residual disease (MRD) detection via circulating tumor DNA (ctDNA) has emerged as a promising approach to identify individuals at high risk of disease recurrence and potentially guide adjuvant therapy decisions.

1 in 3 Primary Care Physicians Have Already Tried AI Scribe Tools

What You Should Know: Elation Health, the clinical-first technology company powering innovation in primary care, today announced the results of a survey of 229 primary

December 14, 2023

Lilly’s diabetes and obesity leader to retire in broader leadership shuffle as CSO Dan Skovronsky takes on immunology role

As Eli Lilly anticipates an FDA weight loss approval for its in-demand diabetes drug Mounjaro by year’s end, the drugmaker’s leader of those two areas

October 5, 2023

Tool Predicts Age at Cognitive Impairment, Dementia Onset

The Florey Dementia Index predicted when cognitive decline or Alzheimer’s dementia would occur. The index is based on age and dementia severity test scores. The

January 10, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.